Related references
Note: Only part of the references are listed.DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Does Impairment of the Ubiquitin-Proteasome System or the Autophagy-Lysosome Pathway Predispose Individuals to Neurodegenerative Disorders such as Parkinson's Disease?
Noriyuki Matsuda et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
CSF alpha-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
Fransje E. Reesink et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Phosphorylated α-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent Manner
Youhei Machiya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
Evangelia Emmanouilidou et al.
JOURNAL OF NEUROSCIENCE (2010)
Imaging Approaches to Parkinson Disease
David J. Brooks
JOURNAL OF NUCLEAR MEDICINE (2010)
Clinical Implications of Gene Discovery in Parkinson's Disease and Parkinsonism
Christian Wider et al.
MOVEMENT DISORDERS (2010)
Plasma α-Synuclein in Patients with Parkinson's Disease With and Without Treatment
Raquel Duran et al.
MOVEMENT DISORDERS (2010)
PARKINSON DISEASE Progress towards a molecular biomarker for Parkinson disease
Penelope Foulds et al.
NATURE REVIEWS NEUROLOGY (2010)
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease
T. Tokuda et al.
NEUROLOGY (2010)
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
Min Shi et al.
NEUROSCIENCE LETTERS (2010)
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
Hong Qing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Biological fluid biomarkers in neurodegenerative parkinsonism
Michael Eller et al.
NATURE REVIEWS NEUROLOGY (2009)
Dissecting the potential molecular mechanisms underlying a-synuclein cell-to-cell transfer in Parkinson's disease
Elodie Angot et al.
PARKINSONISM & RELATED DISORDERS (2009)
Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance
Laura Parkkinen et al.
ACTA NEUROPATHOLOGICA (2008)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein
Katerina E. Paleologou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein aggregation in the brain: The molecular basis for Alzheimer's and Parkinson's diseases
G. Brent Irvine et al.
MOLECULAR MEDICINE (2008)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson disease
Oleg S. Gorbatyuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ultra-high field NMR studies of antibody binding and site-specific phosphorylation of α-synuclein
Hiroaki Sasakawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Plasma α-synuclein is decreased in subjects with Parkinson's disease
Qiao-Xin Li et al.
EXPERIMENTAL NEUROLOGY (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy
P. H. Lee et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Diagnosis and treatment of Parkinson disease: molecules to medicine
Joseph M. Savitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology
O Suchowersky et al.
NEUROLOGY (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Subjective complaints, precede Parkinson disease - The Rotterdam study
LML de Lau et al.
ARCHIVES OF NEUROLOGY (2006)
A systematic review of prevalence and incidence studies of dementia with Lewy bodies
J Zaccai et al.
AGE AND AGEING (2005)
Intravesicular localization and exocytosis of α-synuclein and its aggregates
HJ Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders
OMA El-Agnaf et al.
FASEB JOURNAL (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
α-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
OMA El-Agnaf et al.
FASEB JOURNAL (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Phosphorylation of α-synuclein characteristic of synucleinopathy lesions is recapitulated in α-synuclein transgenic Drosophila
M Takahashi et al.
NEUROSCIENCE LETTERS (2003)
α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
C Lo Bianco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Selective insolubility of α-Synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model
PJ Kahle et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease
AJ Hughes et al.
NEUROLOGY (2001)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
